Paul Hartmann AG (FRA:PHH2) EBIT : €65 Mil (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Paul Hartmann AG EBIT?

Paul Hartmann AG's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was €60 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was €65 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Paul Hartmann AG's annualized ROC % for the quarter that ended in Dec. 2023 was 2.56%. Paul Hartmann AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 10.41%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Paul Hartmann AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 7.88%.

Paul Hartmann AG EBIT Historical Data

The historical data trend for Paul Hartmann AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paul Hartmann AG EBIT Chart

Paul Hartmann AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

106.10

164.86

138.69

65.69

64.81

Paul Hartmann AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial															68.32	8.10	57.59	4.86	59.95

Competitive Comparison of Paul Hartmann AG's EBIT

For the Medical Instruments & Supplies subindustry, Paul Hartmann AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Paul Hartmann AG's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Paul Hartmann AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Paul Hartmann AG's EV-to-EBIT falls into.

Paul Hartmann AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €65 Mil.

Paul Hartmann AG (FRA:PHH2) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Paul Hartmann AG's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	58.088 * ( 1 - 29.91% )	/	( (1630.255	+	1552.351)	/ 2 )
=	40.7138792	/	1591.303
=	2.56 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1994.684	-	364.429	-	( 0	-	max(0, 487.614	-	1088.909	+	0	))
=	1630.255

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1986.787	-	289.304	-	( 145.132	-	max(0, 489.722	-	1037.995	+	145.132	))
=	1552.351

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Paul Hartmann AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	119.898	/	( ( (628.451 + max(601.295, 0))	+	(653.823 + max(418.883, 0)) )	/	2 )
=	119.898	/	( ( 1229.746	+	1072.706 )	/	2 )
=	119.898	/	1151.226
=	10.41 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(440.679	+	539.71	+	108.52)	-	(364.429	+	0	+	123.185)
=	601.295

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(377.429	+	468.461	+	23.366)	-	(289.304	+	0	+	161.069)
=	418.883

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Paul Hartmann AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	64.808	/	822.732
	=	7.88 %

Paul Hartmann AG EBIT Related Terms

Thank you for viewing the detailed overview of Paul Hartmann AG's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Paul Hartmann AG (FRA:PHH2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Paul Hartmann AG (FRA:PHH2) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

PHH2:Germany

Address

Paul-Hartmann-Strasse 12, Heidenheim, DEU, 89522

Website

http://www.hartmann.info

Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.

Executives

Eduard Schleicher	Supervisory Board
Britta Fünfstück	Board of Directors

Paul Hartmann AG (FRA:PHH2) Headlines

No Headlines